Bleomycin sulfate and Neurotoxicity - a phase IV clinical study of FDA data

Summary:

Neurotoxicity is reported as a side effect among people who take Bleomycin sulfate (bleomycin sulfate), especially for people who are male, 30-39 old, have been taking the drug for < 1 month also take Etoposide, and have Hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Neurotoxicity when taking Bleomycin sulfate. It is created by eHealthMe based on reports of 3,635 people who have side effects when taking Bleomycin sulfate from the FDA, and is updated regularly.

What is Bleomycin sulfate?

Bleomycin sulfate has active ingredients of bleomycin sulfate. eHealthMe is studying from 3,652 Bleomycin sulfate users. Check the latest studies of Bleomycin sulfate.

What is Neurotoxicity?

Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system) is found to be associated with 677 drugs and 852 conditions by eHealthMe. Check the latest studies of Neurotoxicity.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 19, 2026

3,635 people reported to have side effects when taking Bleomycin sulfate.
Among them, 35 people (0.96%) have Neurotoxicity.

Could Bleomycin sulfate cause Neurotoxicity?

Among these 35 people:

How long have people been on Bleomycin sulfate when they have Neurotoxicity? *

What is the gender of people who have Neurotoxicity when taking Bleomycin sulfate? *

female: 30.77 %
male: 69.23 %

What is the age of people who have Neurotoxicity when taking Bleomycin sulfate? *

What are other drugs people take besides Bleomycin sulfate? *

Etoposide: 19 people, 54.29%
Cisplatin: 18 people, 51.43%
Vinblastine Sulfate: 14 people, 40.00%
Cyclophosphamide: 9 people, 25.71%
Ifosfamide: 8 people, 22.86%
Methotrexate: 4 people, 11.43%
Doxorubicin Hydrochloride: 4 people, 11.43%
Trimethoprim: 4 people, 11.43%
Prednisone: 3 people, 8.57%
Carboplatin: 3 people, 8.57%

What are other side effects people have besides Neurotoxicity? *

Mucosal Inflammation (infection of mucous membrane): 12 people, 34.29%
Haematotoxicity (toxins that destroy red blood cells): 10 people, 28.57%
Death: 8 people, 22.86%
Rashes (redness): 7 people, 20.00%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 6 people, 17.14%
Hypoaesthesia (reduced sense of touch or sensation): 6 people, 17.14%
Arterial Thrombosis (formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system): 5 people, 14.29%
Peripheral Ischaemia (impaired circulation to an extremity): 5 people, 14.29%
Neutropenic Sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection): 5 people, 14.29%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 4 people, 11.43%

What are the existing conditions these people have? *

Hodgkin's Lymphoma (cancer originating from white blood cells): 7 people, 20.00%
Testicular Germ Cell Cancer (germ cell cancer of testes): 6 people, 17.14%
Testicular Cancer (cancer that develops in the testicles): 5 people, 14.29%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 5 people, 14.29%
Hiv Infection: 3 people, 8.57%
Ewing's Sarcoma (malignant small, round, blue cell tumour): 2 people, 5.71%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 2.86%
Osteosarcoma (a cancerous (malignant) bone tumour): 1 person, 2.86%
Kaposi's Sarcoma (a tumour caused by human herpes virus): 1 person, 2.86%
Hepatosplenic T-Cell Lymphoma (neoplasm comprising medium-sized cytotoxic t-cells that show a significant sinusoidal infiltration in the liver, spleen, and bone marrow): 1 person, 2.86%

* Approximation only. Some reports may have incomplete information.

Do you take Bleomycin sulfate and have Neurotoxicity?

- Check whether Neurotoxicity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bleomycin sulfate:

Bleomycin sulfate (3,652 reports)

Neurotoxicity treatments and more:

Neurotoxicity (16,742 reports)

Browse all side effects of Bleomycin sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neurotoxicity:

Neurotoxicity (677 drugs)

Browse all the conditions that are associated with Neurotoxicity:

Neurotoxicity (852 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bleomycin sulfate (the active ingredients of Bleomycin sulfate) and Bleomycin sulfate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.